/Companies

Biotech Startups

11,050 companies tagged Biotech, with their investors and founders.

Dystrogen Therapeutics

Dystrogen Therapeutics develops chimeric cell therapies created by fusing donor and recipient bone marrow-derived stem cells to address the immune system's response to foreign tissues and donor organs. The company operates in the therapeutics and cell therapy field.

0 investors

DZZOM Delaware

0 investors

Eagle Pharmaceuticals

0 investors

Early Stage Cancer Detection

0 investors

EarlyCell

0 investors

Earth Science Tech

Earth Science Tech, Inc. is a publicly traded company (OTC: ETST) that operates health and wellness brands including Peaks Curative, MisterMeds, RxCompoundStore, and telehealth/consultation offerings. It appears to focus on consumer health products and compounded medications.

0 investors

EBS ACQ

0 investors

Eccrine Systems

0 investors

Echo Therapeutics

0 investors

ECM Technologies

0 investors

ECM Therapeutics

ECM Therapeutics is a regenerative medicine company that develops and manufactures therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and supports tissue restoration after injury. Its platform is based on extracellular matrix science and an associated patent portfolio.

0 investors

EcoGenome

Ecogenome performs molecular genetic testing of individual patients' tumors to identify therapeutic vulnerabilities and guide cancer therapy planning. The company focuses on the molecular genetics of treatment-resistant cancers.

0 investors

Edenbridge Holdings

0 investors

Edison Oncology Holding

Edison Oncology develops innovative cancer therapies through collaboration with leading scientific and clinical experts from the life sciences industry and academic partners.

0 investors

Edison Pharmaceuticals

0 investors

Efferent Labs

0 investors

EIP Pharma

0 investors

Elastrin Therapeutics

Elastrin Therapeutics is a biotechnology company developing therapies intended to reverse vascular calcification and restore arterial elasticity, targeting conditions such as heart attack, stroke and peripheral artery disease. Its platform uses nanoparticles with antibodies that bind to damaged elastin to deliver treatment specifically to sites of calcification, and it works with partners including the NIH and Clemson University.

0 investors

Elastro

0 investors

Elcelyx Therapeutics

0 investors

Electrochemical Oxygen Concepts

0 investors

ElectroCyt

ElectroCyt develops handheld diagnostic devices and health data infrastructure to enable frequent, accessible disease testing and early detection before symptoms appear. The company targets patients and healthcare providers seeking preventive medicine solutions through devices like LifeCounts, a portable blood count analyzer.

0 investors

Eleison Pharmaceuticals

0 investors

Element Diagnostics

0 investors

Other sectors & tags